#today news
3 stories tagged "today news".
Advertise Here
Reach qualified buyersBoost your visibility among pharma sourcing professionals and potential buyers.
- Grow your business with qualified leads
- GDS reports on your ad performance
- Targeted to this product's audience
- Direct enquiries from buyers
- Visibility to pharma professionals
Jemperli Wins Accelerated FDA Approval for a Rectal Cancer Subtype as Most Trial Patients Avoided Surgery
FDA gave Jemperli accelerated approval for dMMR rectal cancer. Most trial patients skipped surgery, but the data are interim. What patients should ask.
Latest news
Showing 1–3 of 3 stories
Ryzumvi Eye Drop Wins FDA Approval for Presbyopia, with 27% Reaching the Main Goal in Its Larger Trial
The FDA approved Ryzumvi eye drops for presbyopia in adults. See how the nightly drop works, trial results, side effects, and what remains unknown.
Zilbrysq Autoinjector Wins FDA Approval for Generalized Myasthenia Gravis, but Patients Must Wait Until Early 2027
FDA approved a once-daily Zilbrysq autoinjector for generalized myasthenia gravis. It launches in early 2027 with the same meningococcal infection…
Advertise on PharmaJungle - Free for 30 Days
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
- 30 days of free advertising
- Visibility across all pages
- Performance report with ad insights
- No setup or registration fee
Exclusive introductory offer for new advertisers
Top sources
Post your requirement
Get offers from suppliers
- Reach pharmaceutical suppliers
- Specify quality standard and quantity
- Set your shipping preference
- Receive offers directly
- Listed on our marketplace
Your product details and requirements may be published on the marketplace.
Create a New Buying Request
Fields marked with * are mandatory.